Weekly Tech+Bio Highlights #53: Eli Lilly Opens Access to AI Models Trained on $1 Billion Worth of R&D Data

Is the first anti-aging drug class on the horizon? Also: David Baker’s new venture; grounding AI in chemistry & current state of medchem platforms

and

Sep 09, 2025

∙ Paid

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button:

Where Tech Meets Bio

Weekly Tech+Bio Highlights #53: Eli Lilly Opens Access to AI Models Trained on $1 Billion Worth of R&D Data

Is the first anti-aging drug class on the horizon? Also: David Baker’s new venture; grounding AI in chemistry & current state of medchem platforms

This post is for paid subscribers